Hui Xu
The University of Texas MD Anderson Cancer Center(US)Wuhan University of Technology(CN)Guangzhou Women and Children Medical Center(CN)Suzhou Municipal Hospital(CN)First Affiliated Hospital of Zhengzhou University(CN)Liaocheng People's Hospital(CN)Beijing Center for Disease Prevention and Control(CN)First Hospital of Lanzhou University(CN)Huazhong University of Science and Technology(CN)Lanzhou University(CN)Nanjing Medical University(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Legal and Regulatory Analysis, Linguistic, Cultural, and Literary Studies, Military Technology and Strategies, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses
Most-Cited Works
- → Liver-Enriched Transcription Factors Regulate MicroRNA-122 That Targets CUTL1 During Liver Development(2010)272 cited
- → A dynamic in vivo-like organotypic blood-brain barrier model to probe metastatic brain tumors(2016)231 cited
- → MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells(2009)204 cited
- → Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy(2022)164 cited
- → Insulin-Like Growth Factor-1 Receptor Is Regulated by microRNA-133 during Skeletal Myogenesis(2011)163 cited
- → β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway(2011)138 cited